2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Pancreatic Cancer Highlights: Is Perioperative mFOLFIRINOX More Beneficial Than Gem/nab-P in Resectable Disease? Should Neoadjuvant Therapy Be Considered for Borderline Resectable Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
828 views
July 14, 2020
Comments 0
Login to view comments.
Click here to Login
GI